| ME THODS

| Animal ethics
were specifically approved under the permits. All capture, handling, anaesthesia and euthanasia were undertaken by or directly supervised by an experienced veterinarian.
| Sample characteristics
Blood and/or brain samples were collected from bats in the Australian states of Queensland, New South Wales and Western Australia, and the Northern Territory between April 1996 and October 2002 (Field, 2005) . Samples were obtained from two cohorts of bats: actively sampled and evidently healthy free-living bats (hereafter referred to as "wild-caught" bats) and sick, injured or recently dead bats submitted to the Queensland Government veterinary laboratory in Brisbane for diagnostic testing ("submitted" bats). Wild-caught bats were typically captured in mist nets or harp traps between dusk and dawn, either as they left or returned to their roost or as they foraged (Epstein & Field, 2011) . Bats from which only blood was taken were typically sampled under inhalation anaesthetic (Jonsson, Johnston, Field, Jong, & Smith, 2004) with individuals released at the point of capture within four hours. Bats from which brain (or brain and blood) samples were taken were humanely euthanised immediately prior to sampling: larger bats (Pteropodidae and Megadermatidae) by a lethal dose of barbiturate (Lethabarb®, 325 mg/ml pentobarbitone sodium, Virbac) intravenously or (diluted 1:3) intraperitoneally and smaller bats (Hipposideridae and Vespertilioniformes) by the inhalation of CO 2 . Event and individual animal data including location, date, genus/species, sex and age were recorded.
| Test characteristics
Fresh brain impression smears were tested for ABLV antigen at the Queensland Government veterinary laboratory using
Impacts
• With Australia historically considered free of lyssaviruses, the emergence/detection of Australian bat lyssavirus (ABLV) posed a risk management challenge in a (then) naïve public and public health landscape.
• Numerous bat taxa have a regular urban presence in Australia, and well-meaning members of the public regularly "rescue" sick and injured bats for rehabilitation through an established carer network.
• While the ABLV infection prevalence in wild-caught bats is low, the significantly higher infection prevalence in rescued sick and injured bats represents a clear and present public health danger because of the higher risk of human exposure.
fluorescein-labelled anti-rabies monoclonal globulin (CENTOCOR) in a direct fluorescent antibody test (FAT). Smears were made from at least three sites (medulla, cerebellum and hippocampus) on the cut brain surface. Antigen detection provides direct evidence of current infection.
Sera were forwarded to the Australian Animal Health Laboratory (AAHL) in Geelong for testing for the presence of neutralising antibodies using the rapid fluorescent focus inhibition test (RFFIT), as reported by Smith, Yager, and Baer (1973) . Briefly, the method entails infecting BHK-21 cells with a tissue culture-adapted rabies virus (CVS-11). Subsequently, an equal volume of challenge virus is added to serum dilutions, and after 24 hr of incubation, the number of fluorescing fields counted. The criterion for positivity was a 50% reduction in infectious centres relative to a positive (NIH reference serum) control. Given the absence of classical rabies or other serotype 1 lyssaviruses in Australia, this assay provided a practical screening test while a specific ABLV RFFIT was being developed. Antibody detection provides indirect evidence of past exposure or infection.
| Analysis
Descriptive summary statistics are used to describe the data. Within sample cohorts, 95% confidence intervals are used to indicate significant difference. Sparse data precluded definitive statistical analyses.
| RE SULTS
A total of 3,217 brain and/or blood samples were collected from 2,633 bats ( Figure 1 ). Brain samples were collected from 2,547 bats, being 1,461 wild-caught bats (Table 1 ) and 1,086 submitted bats (Table 2) .
Individuals from at least 16 genera and seven families (44 submitted 
| D ISCUSS I ON
Despite its first description in 1996, there has been limited investigation of the eco-epidemiology of ABLV in Australian bats (Barrett, 2004; Field, 2005) . This report shows that ABLV is taxonomically impediment to the direct detection of infection in these species and to a more complete elaboration of the ecology and phylogeny of ABLV in Australian bats. That said, it appears evident from the findings that Pteropus spp. and S. flaviventris play an important role in the ecology of ABLV. This is supported by phylogenetic analyses to date, which identify two distinct virus clades reflecting sequence variation in Pteropus spp. and S. flaviventris isolates (Warrilow et al., 2002) . Given bat diversity in Australia, it is probable that targeted surveillance will reveal further diversity. Such surveillance might usefully focus on the Mollosidae and Vespertilionidae, both of which had multiple genera in which antibodies were detected.
Generically, antibodies provide indirect evidence of past exposure or infection. However, serology has been an irrelevant lyssavirus surveillance tool in nonbat species because of a near 100% case fatality rate. The putative adapted ancestral reservoir of lyssaviruses , bats are the only taxa in which antibodies are detected with sufficient frequency to support serosurveillance. The crude antibody prevalence in wild-caught bats in this study was 18%. Some taxa yielded high antibody prevalence in very small sample sizes; conversely, no antibodies were detected in Miniopterus notwithstanding a reasonably large sample size across multiple locations and times. Arguin et al. (2002) reported an anti-ABLV antibody prevalence of 9.5% (22/231) in a multigenera sample of Philippine bats (including Miniopterus) using a RFFIT with a specific ABLV antigen. The detection of only five antibody-positive individuals in a parallel RFITT using rabies virus 
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